Fredag 25 April | 20:27:32 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-02-04 07:30 Bokslutskommuniké 2025
2025-10-22 07:30 Kvartalsrapport 2025-Q3
2025-07-18 07:30 Kvartalsrapport 2025-Q2
2025-05-28 N/A Årsstämma
2025-05-12 N/A X-dag ordinarie utdelning TOBII 0.00 SEK
2025-05-07 07:30 Kvartalsrapport 2025-Q1
2025-02-04 - Bokslutskommuniké 2024
2025-01-10 - Extra Bolagsstämma 2025
2024-10-25 - Kvartalsrapport 2024-Q3
2024-07-19 - Kvartalsrapport 2024-Q2
2024-05-24 - X-dag ordinarie utdelning TOBII 0.00 SEK
2024-05-23 - Årsstämma
2024-05-16 - Kvartalsrapport 2024-Q1
2024-03-04 - Extra Bolagsstämma 2024
2024-02-01 - Bokslutskommuniké 2023
2023-11-07 - Kvartalsrapport 2023-Q3
2023-07-21 - Kvartalsrapport 2023-Q2
2023-05-29 - X-dag ordinarie utdelning TOBII 0.00 SEK
2023-05-26 - Årsstämma
2023-05-04 - Kvartalsrapport 2023-Q1
2023-02-07 - Bokslutskommuniké 2022
2022-11-08 - Kvartalsrapport 2022-Q3
2022-08-23 - Kvartalsrapport 2022-Q2
2022-05-27 - X-dag ordinarie utdelning TOBII 0.00 SEK
2022-05-25 - Årsstämma
2022-05-05 - Kvartalsrapport 2022-Q1
2022-02-08 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-10-25 - Extra Bolagsstämma 2021
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-19 - X-dag ordinarie utdelning TOBII 0.00 SEK
2021-04-29 - Kvartalsrapport 2021-Q1
2021-02-04 - Bokslutskommuniké 2020
2020-10-29 - Kvartalsrapport 2020-Q3
2020-08-19 - Kvartalsrapport 2020-Q2
2020-05-13 - X-dag ordinarie utdelning TOBII 0.00 SEK
2020-05-12 - Årsstämma
2020-04-29 - Kvartalsrapport 2020-Q1
2020-02-06 - Bokslutskommuniké 2019
2019-10-24 - Kvartalsrapport 2019-Q3
2019-07-19 - Kvartalsrapport 2019-Q2
2019-05-10 - X-dag ordinarie utdelning TOBII 0.00 SEK
2019-05-09 - Årsstämma
2019-04-26 - Kvartalsrapport 2019-Q1
2019-02-06 - Bokslutskommuniké 2018
2018-10-25 - Kvartalsrapport 2018-Q3
2018-07-20 - Kvartalsrapport 2018-Q2
2018-05-09 - X-dag ordinarie utdelning TOBII 0.00 SEK
2018-05-08 - Årsstämma
2018-04-26 - Kvartalsrapport 2018-Q1
2018-02-08 - Bokslutskommuniké 2017
2017-10-26 - Kvartalsrapport 2017-Q3
2017-07-25 - Kvartalsrapport 2017-Q2
2017-05-10 - X-dag ordinarie utdelning TOBII 0.00 SEK
2017-05-09 - Årsstämma
2017-04-27 - Kvartalsrapport 2017-Q1
2017-02-15 - Bokslutskommuniké 2016
2016-11-30 - Extra Bolagsstämma 2016
2016-10-27 - Kvartalsrapport 2016-Q3
2016-07-28 - Kvartalsrapport 2016-Q2
2016-05-12 - X-dag ordinarie utdelning TOBII 0.00 SEK
2016-05-11 - Årsstämma
2016-05-04 - Kvartalsrapport 2016-Q1
2016-02-16 - Bokslutskommuniké 2015
2015-11-03 - Kvartalsrapport 2015-Q3
2015-08-05 - Kvartalsrapport 2015-Q2
2015-06-10 - Årsstämma
2015-05-22 - Kvartalsrapport 2015-Q1
2015-05-20 - Bokslutskommuniké 2014

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorInformationsteknik
IndustriElektronisk utrustning
Tobii är verksamma inom IT-sektorn. Bolaget utvecklar tekniska lösningar för eye-tracking, som gör det möjligt för datorer att veta vart användaren tittar. Olika lösningar som bolaget utvecklar är för närvarande kommunikationslösningar för personer med rörelsehinder eller kommunikationssvårigheter, samt tillhörande utrustning inom arbetsområdet. Kunder återfinns huvudsakligen inom forskningsinstitut, tillbehör inom VR för speldatorer, samt inom sjukvård. Huvudkontoret ligger i Danderyd.
2025-03-26 09:00:00

Tobii, the global leader in eye tracking and attention computing, has partnered with CitrusBits, a developer of healthcare-focused digital solutions, to enhance medical training, diagnostics, and rehabilitation through XR. By integrating Tobii’s industry-leading eye tracking technology and Tobii Ocumen into CitrusBits IntelliXR™, this collaboration improves clinical simulations, supports personalized rehabilitation, and enhances patient care with real-time insights.

CitrusBits IntelliXR™ integrates Tobii eye tracking into its XR headset and connected device ecosystem, enabling healthcare professionals to conduct advanced medical simulations, improve diagnostics, and personalize rehabilitation programs. The platform provides built-in regulatory support, secure device management, and cloud-based services, ensuring compliance with industry standards while enhancing cognitive and visual attention analysis in medical applications.

“Eye tracking is transforming healthcare assessment and therapy by providing deeper insights into human attention and behavior,” said Emma Bauer, senior vice president of Integrations at Tobii. “Our collaboration with CitrusBits brings Tobii‘s eye tracking technology to the forefront, making XR applications more capable, precise, and effective.”

The new headset from CitrusBits and its platform are designed for seamless clinical adoption, featuring:

  • Real-time user behavior analysis powered by Tobii’s high-precision eye tracking
  • Flexible optical system that adjusts for different medical visualization requirements
  • Secure, HIPAA-compliant software to protect patient data
  • Built-in support for regulatory approvals like FDA 510(k)

Additionally, integrating Tobii Ocumen, a high-performance developer toolkit, simplifies the adoption of eye tracking in XR applications. This ensures faster deployment and broader adoption of CitrusBits IntelliXR™ across medical and rehabilitation use cases.

The CitrusBits IntelliXR™ headset is expected to be available for purchase in the Americas, Europe, Asia, and Oceania by Q3 2025. 
 
"CitrusBits IntelliXR™ is bridging the gap between cutting-edge technology and practical healthcare applications," said Gaurav Malik, chief commercial officer at CitrusBits. "By integrating eye tracking into XR, we’re equipping healthcare professionals with smarter tools to enhance training, refine diagnostics, and ultimately improve patient outcomes. Our goal is to reach over 100,000 individuals in the next three years."

You can learn more about Tobii´s extended reality integrations offering here.

For more information, please contact:
Rasmus Löwenmo Buckhöj, Head of Communications, Tobii AB, phone: +46 (0)73 327 87 64, email: rasmus.lowenmobuckhoj@tobii.com

About Tobii 
Tobii is the global leader in eye tracking and pioneer of attention computing. We are on a mission to improve the world with technology that understands human attention and intent. Creating tech for a better future, our technologies and solutions apply to areas such as behavioral studies and research, healthcare, education and training, gaming, extended reality, automotive, and many more. Tobii's eye tracking is used by thousands of enterprises, universities, and research institutes around the globe. Headquartered in Sweden, Tobii is listed on Nasdaq Stockholm (TOBII). For more information: www.tobii.com.